Mycenax Biotech Strategic Asset Allocation Index
Mycenax Biotech strategic asset allocation index. Mycenax Biotech (4726) has a Strategic Asset Allocation Index of 69.9% as of June 2023. Strategic assets (PP&E of NT$1.90 Billion plus long-term investments of NT$-) total NT$1.90 Billion, measured against net assets of NT$2.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 4726 equity financing ratio to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Mycenax Biotech (2017–2022)
Strategic asset allocation index of Mycenax Biotech from 2017 to 2022. This chart shows how Mycenax Biotech's Strategic Asset Allocation Index has evolved across 6 annual periods from 2017 to 2022. As of June 2023, the index stands at 69.9%, representing strategic assets of NT$1.90 Billion against net assets of NT$2.72 Billion TWD. Check Mycenax Biotech (4726) tangible net worth to evaluate the tangible quality of the company's equity base.
Mycenax Biotech Strategic Asset Allocation Index by Year (2017–2022)
Mycenax Biotech strategic asset allocation index by year from 2017 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Mycenax Biotech from 2017 to 2022, covering 6 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see Mycenax Biotech (4726) total market value.
| Year | SAAI | Strategic Assets (TWD) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 63.7% | NT$1.98 Billion | NT$1.98 Billion | NT$- | NT$3.11 Billion | ▼ -7.1 pp |
| 2021 | 70.8% | NT$1.35 Billion | NT$1.35 Billion | NT$- | NT$1.91 Billion | ▲ +5.9 pp |
| 2020 | 64.9% | NT$786.73 Million | NT$786.73 Million | NT$- | NT$1.21 Billion | ▲ +11.1 pp |
| 2019 | 53.8% | NT$592.84 Million | NT$592.84 Million | NT$- | NT$1.10 Billion | ▲ +7.0 pp |
| 2018 | 46.8% | NT$424.89 Million | NT$424.89 Million | NT$- | NT$907.01 Million | ▲ +15.0 pp |
| 2017 | 31.8% | NT$363.83 Million | NT$363.83 Million | NT$- | NT$1.14 Billion | — |